Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently accepted at: JMIRx Med

Date Submitted: Mar 17, 2026
Date Accepted: May 20, 2026

This paper has been accepted and is currently in production.

It will appear shortly on 10.2196/95524

The final accepted version (not copyedited yet) is in this tab.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Factors Influencing Hemoglobin Variability and Its Prognostic Implications in Chronic Kidney Disease in dialysis patients.

  • Masoud Mohamed Mtore; 
  • Ahmed Maulid Kombo; 
  • innocent Tesha; 
  • Mashaka Hassan Mrisho; 
  • Khadija Mussa Assad; 
  • Fahad Omar Nofli; 
  • Dongqi Ye; 
  • Jianxin Zhang; 
  • Xuxiao Xue; 
  • GangYi Wang; 
  • HongLi Zhou

ABSTRACT

Background:

Chronic Kidney Disease (CKD) is a global health burden with a high prevalence of anemia, which is largely driven by impaired erythropoiesis due to reduced erythropoietin production, iron deficiency, and chronic inflammation. Hemoglobin variability, defined as fluctuations in hemoglobin levels over time, has emerged as a key factor influencing the prognosis of CKD patients. While anemia is well-recognized in CKD, the implications of hemoglobin variability on patient outcomes, including mortality, cardiovascular events, and hospitalization, remain insufficiently explored.

Objective:

Primary Objectives. (1).To identify and quantify factors contributing to hemoglobin variability in CKD patients. (2).To evaluate the relationship between hemoglobin variability and prognosis, including mortality, cardiovascular outcomes, frequency of hospitalization and length of hospital stay. Secondary Objectives. (1).To explore potential strategies for minimizing hemoglobin variability in CKD patients.

Methods:

This retrospective cohort study aimed to identify the factors that contribute to hemoglobin variability in CKD patients and to assess its relationship with clinical outcomes. By analyzing electronic medical records (EMRs) in The First Affiliated Hospital of Jinzhou Medical University, the study evaluated data from patients with CKD stage 5, including those on dialysis, who had at least 12 months of recorded hemoglobin levels. Different factors were examined to quantify their influence on hemoglobin fluctuations. Also, the study analyzed the relationship between hemoglobin variability and outcomes .

Results:

A total of 504 participants were included. Males were 58.7% and 41.3% females. Over one third of the participants (36.9%) were elderly. Only 3.0% had a hemoglobin that remained in the normal target range (11.0 and 12.5 g/dl) at all measurements done. Majority of the participants (78.4%) had a hemoglobin that remained low (<11.0 g/dl). Only 1.8% had a hemoglobin that remained about the target range (>12.5 g/dl). Using the standard deviation, the median variability was 0.56 g/dl, 0.90 g/dl when using absolute range and 6.73% when using coefficient of variation. After categorizing the findings of variability, 30.0% were considered to have high variability which was defined by having variability above the upper quartile using either the standard deviation, the absolute range or the coefficient of variation. In the multivariable analysis, the independent factors contributing to hemoglobin variability in CKD patients were: age below 30 years (aOR=3.557, CI=1.522-8.314, P=0.003), diabetes mellitus (aOR=1.586, CI=1.048-2.401, P=0.029), elevated interleukin 6 (aOR=3.522, CI=1.972-6.289, P<0.001), low albumin (aOR=1.961, CI=1.257-3.060, P=0.003), high CRP (aOR=2.228, CI=1.204-4.125, P=0.011) and low ferritin levels (aOR=3.185, CI=2.019-5.025, P<0.001). Regarding prognosis, a significant association was found regarding mortality, length of hospital stays and frequency of admissions. No significant association was found regarding cardiovascular events.

Conclusions:

Almost all participants had their Hb levels deranged from the normal target range. Patients below 30 years, those having diabetes mellitus, those with infection, low ferritin or low albumin among CKD patients should be given special attention and care as they are at a higher risk of suffering hemoglobin variation that worsens prognosis. All CKD patients with hemoglobin variability should be followed up more closely to minimize mortality and morbidity, given that it was highly associated with both outcomes .


 Citation

Please cite as:

Mtore MM, Kombo AM, Tesha i, Mrisho MH, Assad KM, Nofli FO, Ye D, Zhang J, Xue X, Wang G, Zhou H

Factors Influencing Hemoglobin Variability and Its Prognostic Implications in Chronic Kidney Disease in dialysis patients.

JMIR Preprints. 17/03/2026:95524

DOI: 10.2196/preprints.95524

URL: https://preprints.jmir.org/preprint/95524

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.